Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans

Open Access

1 May 2001

journal article
clinical trial
Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy

Vol. 47 (5) , 709-710
https://doi.org/10.1093/jac/47.5.709

Abstract

To examine the efficacy of Lactobacillus gasseri OLL2716 (LG21) as a probiotic for Helicobacter pylori in humans, 31 subjects infected with the bacterium ingested yogurt containing LG21 daily for an 8 week period. The [¹³C]urea breath test and assays of serum pepsinogens revealed a significant improvement following LG21 treatment. LG21 was thus determined to be effective in both suppressing H. pylori and reducing gastric mucosal inflammation.

Keywords

This publication has 5 references indexed in Scilit:

Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans
Digestion, 1999
Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model
American Journal of Gastroenterology, 1998
The¹³C-urea breath test as a predictor of intragastric bacterial load and severity ofHelicobacter pylorigastritis
Scandinavian Journal of Clinical and Laboratory Investigation, 1998
Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.
Gut, 1995
Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology
Gastroenterology, 1982